|
Volume 271, Number 37,
Issue of September 13, 1996
pp. 22663-22671
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
The Highly Stereoselective Oxidation of Polyunsaturated Fatty
Acids by Cytochrome P450BM-3
(Received for publication, April 15, 1996, and in revised form, July 2, 1996)
Jorge H.
Capdevila
§
,
Shozou
Wei
§
,
Christian
Helvig
§
,
John R.
Falck
¶
,
Yuri
Belosludtsev
¶
,
Gilles
Truan
,
Sandra
E.
Graham-Lorence
and
Julian A.
Peterson
From Departments of Biochemistry and ¶ Molecular
Genetics, The University of Texas Southwestern Medical Center at
Dallas, Dallas, Texas 75325-9038 and Departments of
§ Medicine and Biochemistry, Vanderbilt
University Medical School, Nashville, Tennessee 37232
Cytochrome P450BM-3 catalyzes
NADPH-dependent metabolism of arachidonic acid to nearly
enantiomerically pure 18(R)-hydroxyeicosatetraenoic acid
and 14(S),15(R)-epoxyeicosatrienoic acid (80 and 20% of total products, respectively). P450BM-3 oxidizes
arachidonic acid with a rate of 3.2 ± 0.4 µmol/min/nmol at
30 °C, the fastest ever reported for an NADPH-dependent,
P450-catalyzed reaction. Fatty acid, oxygen, and NADPH are utilized in
an approximately 1:1:1 molar ratio, demonstrating efficient coupling of
electron transport to monooxygenation.
Eicosapentaenoic and eicosatrienoic acids, two arachidonic acid analogs
that differ in the properties of the C-15-C-18 carbons, are also
actively metabolized by P450BM-3 (1.4 ± 0.2 and 2.9 ± 0.1 µmol/min/nmol at 30 °C, respectively). While the 17,18-olefinic
bond of eicosapentaenoic acid is epoxidized with nearly absolute regio-
and stereochemical selectivity to
17(S),18(R)-epoxyeicosatetraenoic acid ( 99%
of total products, 97% optical purity), P450BM-3 is only moderately
regioselective during hydroxylation of the eicosatrienoic acid -1,
-2, and -3 sp3 carbons, with 17-, 18-, and 19-hydroxyeicosatrienoic acid formed in a ratio of 2.4:2.2:1,
respectively.
Based on the above and on a model of arachidonic acid-bound P450BM-3,
we propose: 1) the formation by P450BM-3 of a single oxidant species
capable of olefinic bond epoxidation and sp3
carbon hydroxylation and 2) that product chemistry and, thus, catalytic
outcome are critically dependent on active site spatial coordinates
responsible for substrate binding and productive orientation between
heme-bound active oxygen and acceptor carbon bond(s).

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Fer, L. Corcos, Y. Dreano, E. Plee-Gautier, J.-P. Salaun, F. Berthou, and Y. Amet
Cytochromes P450 from family 4 are the main omega hydroxylating enzymes in humans: CYP4F3B is the prominent player in PUFA metabolism
J. Lipid Res.,
November 1, 2008;
49(11):
2379 - 2389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Jungmann, I. Molnar, P. E. Hammer, D. S. Hill, R. Zirkle, T. G. Buckel, D. Buckel, J. M. Ligon, and J. P. Pachlatko
Biocatalytic Conversion of Avermectin to 4"-Oxo-Avermectin: Characterization of Biocatalytically Active Bacterial Strains and of Cytochrome P450 Monooxygenase Enzymes and Their Genes
Appl. Envir. Microbiol.,
November 1, 2005;
71(11):
6968 - 6976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Arita, M. Yoshida, S. Hong, E. Tjonahen, J. N. Glickman, N. A. Petasis, R. S. Blumberg, and C. N. Serhan
Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis
PNAS,
May 24, 2005;
102(21):
7671 - 7676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. S. Wong, N. Wu, D. Roccatano, M. Zacharias, and U. Schwaneberg
Sensitive Assay for Laboratory Evolution of Hydroxylases toward Aromatic and Heterocyclic Compounds
J Biomol Screen,
April 1, 2005;
10(3):
246 - 252.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Arita, F. Bianchini, J. Aliberti, A. Sher, N. Chiang, S. Hong, R. Yang, N. A. Petasis, and C. N. Serhan
Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1
J. Exp. Med.,
March 7, 2005;
201(5):
713 - 722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Lauterbach, E. Barbosa-Sicard, M.-H. Wang, H. Honeck, E. Kargel, J. Theuer, M. L. Schwartzman, H. Haller, F. C. Luft, M. Gollasch, et al.
Cytochrome P450-Dependent Eicosapentaenoic Acid Metabolites Are Novel BK Channel Activators
Hypertension,
February 1, 2002;
39(2):
609 - 613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Schwaneberg, C. Otey, P. C. Cirino, E. Farinas, and F. H. Arnold
Cost-Effective Whole-Cell Assay for Laboratory Evolution of Hydroxylases in Escherichia coli
J Biomol Screen,
April 1, 2001;
6(2):
111 - 117.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. N. Serhan, C. B. Clish, J. Brannon, S. P. Colgan, N. Chiang, and K. Gronert
Novel Functional Sets of Lipid-derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2-Nonsteroidal Antiinflammatory Drugs and Transcellular Processing
J. Exp. Med.,
October 16, 2000;
192(8):
1197 - 1204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Capdevila, J. R. Falck, and R. C. Harris
Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase
J. Lipid Res.,
February 1, 2000;
41(2):
163 - 181.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Schneider, M. G. Wubbolts, D. Sanglard, and B. Witholt
Biocatalyst Engineering by Assembly of Fatty Acid Transport and Oxidation Activities for In Vivo Application of Cytochrome P-450BM-3 Monooxygenase
Appl. Envir. Microbiol.,
October 1, 1998;
64(10):
3784 - 3790.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. N. A. Palmer, E. Axen, V. Hughes, and C. R. Wolf
The Repressor Protein, Bm3R1, Mediates an Adaptive Response to Toxic Fatty Acids in Bacillus megaterium
J. Biol. Chem.,
July 17, 1998;
273(29):
18109 - 18116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Spencer, J. W. Woods, T. Arakawa, I. I. Singer, and W. L. Smith
Subcellular Localization of Prostaglandin Endoperoxide H Synthases-1 and -2 by Immunoelectron Microscopy
J. Biol. Chem.,
April 17, 1998;
273(16):
9886 - 9893.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bylund, T. Kunz, K. Valmsen, and E. H. Oliw
Cytochromes P450 with Bisallylic Hydroxylation Activity on Arachidonic and Linoleic Acids Studied with Human Recombinant Enzymes and with Human and Rat Liver Microsomes
J. Pharmacol. Exp. Ther.,
January 1, 1998;
284(1):
51 - 60.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Graham-Lorence, G. Truan, J. A. Peterson, J. R. Falck, S. Wei, C. Helvig, and J. H. Capdevila
An Active Site Substitution, F87V, Converts Cytochrome P450 BM-3 into a Regio- and Stereoselective (14S,15R)-Arachidonic Acid Epoxygenase
J. Biol. Chem.,
January 10, 1997;
272(2):
1127 - 1135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Hoch, J. R. Falck, and P. R. O. de Montellano
Molecular Basis for the omega -Regiospecificity of the CYP4A2 and CYP4A3 Fatty Acid Hydroxylases
J. Biol. Chem.,
August 25, 2000;
275(35):
26952 - 26958.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|